Acino ? Delivering Health

Entering emerging markets -
hurdles to overcome
Entry of emerging markets
– Highly fragmented regulatory environment
> Increased requirements for stability (Zone IVB)
> Local bioequivalence / clinical studies required
> Trends toward local production
> Limited uptake of alternative generic products by authorities
Market environment
– Market size
– Many markets are flooded with cheap commodities (Indian/Chinese/local origin)
– Many markets are dispensing markets (low quantities/low turnover)
– Patients pay out of their own pocket, decision making done by physician/patient
(brand equity)
42